Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors vs Chemotherapy

• Main Authors: Zheng Y (Author), Yu T (Author), Mackey RH (Author), Gayle JA (Author), Wassel CL (Author), Phatak H (Author), Kim R (Author)
• Format: Book
• Published: Dove Medical Press, 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ying Zheng,1 Ting Yu,2 Rachel H Mackey,3,4 Julie A Gayle,3 Christina L Wassel,3 Hemant Phatak,1 Ruth Kim5 1 EMD Serono, Inc., Rockland, USA; An Affiliate of Merck KGaA, Darmstadt, Germany; 2Global Medical Affairs, EMD Serono, Inc., Rockland, MA, USA; An Affiliate of Merck KGaA, Darmstadt, Germany; 3...